AzaSite FDA Approval History
FDA Approved: Yes (First approved April 27, 2007)
Brand name: AzaSite
Generic name: azithromycin
Dosage form: Ophthalmic Solution
Company: InSite Vision Incorporated
Treatment for: Conjunctivitis, Bacterial
AzaSite is an ophthalmic formulation of the well-known, broad-spectrum antibiotic azithromycin indicated for the treatment of bacterial conjunctivitis.
Development timeline for AzaSite
| Date | Article |
|---|---|
| Apr 29, 2007 | Approval Inspire Announces FDA Approval Of AzaSite |
| Aug 28, 2006 | InSite Vision Announces FDA Acceptance of New Drug Application for Review |
| Jun 29, 2006 | InSite Vision Announces Submission of AzaSite NDA |
| Apr 27, 2006 | InSite Vision Meets With the FDA on Pre-NDA Discussions |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
